ABBV vs GEHC
By Alex · Tickerpine
AbbVie Inc. vs GE HealthCare Technologies Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | GEHC |
|---|---|---|
| Price | $295.03 | $83.02 |
| Market cap | $521.50B | $37.54B |
| P/E ratio | 50.7 | 17.6 |
| ROE | — | 20.01% |
| Profit margin | 15.67% | 9.95% |
| Revenue growth | 10.30% | 7.20% |
| Dividend yield | 2.35% | 0.19% |
| Beta | 0.19 | 0.77 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs GEHC in plain English
- ABBV is the bigger company — about 13.9× the market cap of GEHC.
- GEHC is cheaper on earnings (P/E 17.6 vs 50.7).
- ABBV is growing revenue faster (10% vs 7%).
- ABBV has the higher dividend yield (2.35% vs 0.19%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
GEHC return calculator
See what $1,000 in GE HealthCare Technologies Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.